Edelman is the managing member of Perceptive Advisors and may be deemed to beneficially own the securities directly held by the Master Fund and (iv) the business address of each of Master Fund, Perceptive Advisors and Mr. Edelman is 51 Astor Place, 10th Floor, New York, NY 10003. The amount included in this line does not include a warrant exercisable for 990,330 shares of Menlo common stock as such warrant is not currently exercisable.
(2)
Mr. Basta served as the Company’s Chief Executive Officer until the Closing Date. The amount included in this line item includes 536,537 shares of common stock and 783,300 shares of common stock underlying options that are currently exercisable. These options were accelerated and vested in full upon the Merger. This amount does not include 45,000 shares of common stock underlying options that have not vested and do not vest within 60 days of June 9, 2020.
(3)
Ms. Ball served as the Company’s Chief Financial Officer until the Closing Date. The amount included in this line item includes 52,534 shares of common stock and 333,123 shares of common stock underlying options that are currently exercisable. These options were accelerated and vested in full upon the Merger.
(4)
Dr. Kwon served as the Companys Chief Scientific Officer until the Closing Date. The amount included in this line item includes 52,534 shares of common stock and 316,512 shares of common stock underlying options that are currently exercisable. These options were accelerated and vested in full upon the Merger.
(5)
Includes 195,250 shares of common stock and 1,268,387 shares of common stock underlying equity awards that are exercisable or will become exersiable within 60 days of June 9, 2020. This line item does not include 1,051,955 shares of common stock underlying RSUs and 1,566,461 shares of common stock underlying options that do not vest within 60 days of June 9, 2020.
(6)
Includes 88,971 shares of common stock underlying options that have vested. Does not include 45,000 shares of common stock underlying options that do not vest within 60 days of June 9, 2020.
(7)
Includes 226,378 shares of common stock underlying options that have vested and 2,427 shares of common stock underlying options that will vest within 60 days of June 9, 2020. Does not include 106,227 shares of common stock underlying options that do not vest within 60 days of June 9, 2020.
(8)
Includes 115,192 shares of common stock. Does not include 52,173 shares of common stock underlying equity awards that do not vest within 60 days of June 9, 2020.
(9)
Ms. Sandoval served on the Board prior to the Merger and continues to serve on our Board. The amount included in this line item includes 45,000 shares underlying options that are currently exercisable. These options were accelerated and vested in full upon the Merger. This amount does not include 45,000 shares of common stock underlying options that have not vested and do not vest within 60 days of June 9, 2020.
(10)
Includes 978,005 shares of common stock and 2,744,105 shares of common stock underlying equity awards that have vested or will vest within 60 days of June 9, 2020. Does not include 5,030,050 shares of common stock underlying equity awards that do not vest within 60 days of June 9, 2020.
Securities Authorized for Issuance Under Equity Compensation Plans
The following table contains information about our equity compensation plans as of June 5, 2020. As of June 5, 2020, we had three equity compensation plans, our 2018 Plan, our 2019 Plan and 2019 Employee Share Purchase Plan, which have been approved by our board of directors and our stockholders.